Shares of the direct-to-consumer telehealth company Hims & Hers have been halved over the past six months, trading near $27. Investors are now weighing whether the steep sell-off presents a buying opportunity or signals deeper troubles ahead.
As AI spending surges, investors face a classic choice: TSMC, the indispensable manufacturer powering the entire industry, or AMD, the aggressive designer aiming to dethrone Nvidia. We analyze the risk-reward calculus.
Mitsubishi UFJ Financial Group's shares have surged nearly 50% in the past year, capping a remarkable five-year run. As the stock trades near ¥2,751, investors are divided: does the valuation still offer a margin of safety, or has the rally run its course? We delve into the metrics and market sentiment.
Sanmina posted robust Q4 revenue, fueled by communications and AI infrastructure demand, yet shares fell as investors scrutinized softer margins and the integration of ZT Systems. Analysts on the earnings call zeroed in on the path to profitability and market diversification.
Fidelity data reveals the average millennial 401(k) balance stands at $67,300. While the figure may seem modest, financial experts argue it represents a solid foundation for a generation that entered the workforce during economic turmoil.
Meta Platforms' shares soared following a robust Q4 earnings beat and aggressive AI investment plans. While core advertising thrives, the company's massive capital expenditure hike raises questions about long-term payoff and competitive positioning.
Takeda Pharmaceutical raises its FY2025 revenue and profit guidance following resilient nine-month results and announces U.S. availability of a new ready-to-use immunoglobulin therapy for primary immunodeficiency, fueling discussions on its growth strategy amid high debt and margin pressures.
Harmony Biosciences CFO Sandip Kapadia has liquidated his entire direct stake in the company, a move that contrasts sharply with the firm's robust financial performance and bullish $1 billion revenue target for its flagship drug WAKIX by 2026. While the sales were pre-planned, the timing fuels debate on insider confidence versus corporate optimism.
Nepali authorities have arrested six executives from travel and rescue companies, alleging a sophisticated fraud scheme involving fabricated high-altitude rescues to bilk international insurers out of nearly $20 million.
After a staggering 75% surge over the past year, Tapestry's stock is under the microscope. While a discounted cash flow model suggests the shares are roughly fairly valued, its sky-high P/E ratio tells a more cautionary tale, raising questions about whether the market's optimism has gotten ahead of itself.
Chinese authorities have executed four individuals convicted of running a multi-billion dollar telecom fraud and gambling network from Myanmar, responsible for six deaths. The move follows last week's execution of 11 others, signaling Beijing's intensifying campaign against organized cybercrime in Southeast Asia.
Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.
Despite a recent share price surge, Gear4music's underlying financial performance, marked by a declining ROE and shrinking earnings, paints a concerning picture. Analysts question the disconnect and the company's strategy as it navigates a challenging retail landscape.
In a landmark deal set to reshape global aluminum supply chains, Aluminum Corporation of China (Chalco) and mining giant Rio Tinto have jointly acquired a controlling interest in Brazil's Companhia Brasileira de Alumínio (CBA). This strategic move marks Chalco's largest overseas investment to date, significantly expanding its international footprint and influence.
Shares of Kalmar Oyj have soared nearly 40% over the past year, outpacing broader market sentiment. As the stock consolidates near €43, investors are questioning whether the rally still has legs or if the easy money has been made. A deep dive into valuation metrics suggests there may be more room to run.
Laura Fernández, former chief of staff to President Rodrigo Chaves, holds a commanding lead and could secure an outright victory, promising to double down on the incumbent's hardline security agenda.
After a challenging transitional year in 2025, Navitas Semiconductor's pivot towards high-margin data center and industrial markets is expected to accelerate growth and deliver investor returns by 2026, despite near-term revenue pressures.
Newly released documents from the Jeffrey Epstein case detail his repeated interactions with Vladimir Putin and Russian intelligence, raising serious questions about whether the financier's sex trafficking network doubled as a foreign kompromat operation.
Voters head to the polls in Costa Rica, with the ruling right-wing populist party aiming to secure a decisive mandate and a legislative supermajority to tackle record violence and political gridlock.
Tens of thousands gathered in Prague's Wenceslas Square on Sunday, voicing support for President Petr Pavel in his escalating constitutional dispute with Prime Minister Andrej Babiš's coalition government. The protest, organized by pro-democracy activists, highlights deep divisions over Ukraine policy and a controversial ministerial appointment.
